510(k) K780729

LAS-R HUMAN COMPLEMENT CLQ TEST by Hyland Therapeutic Div., Travenol Laboratories — Product Code DAK

K780729 is an FDA 510(k) premarket notification submitted by Hyland Therapeutic Div., Travenol Laboratories for the device "LAS-R HUMAN COMPLEMENT CLQ TEST". The FDA issued a decision of Substantially Equivalent on May 18, 1978. The device falls under product code DAK (Complement C1q, Antigen, Antiserum, Control), a Class II device regulated under 21 CFR 866.5240. Hyland Therapeutic Div., Travenol Laboratories has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
May 18, 1978
Date Received
May 2, 1978
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Complement C1q, Antigen, Antiserum, Control
Device Class
Class II
Regulation Number
866.5240
Review Panel
IM
Submission Type